- Home
- CYRX
CYRX
CryoPort Inc.
as 12-20-2024 4:00pm EST
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | BRENTWOOD |
| Market Cap: | 381.6M | IPO Year: | N/A |
| Target Price: | $13.14 | AVG Volume (30 days): | 446.9K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.39 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.32 - $20.11 | Next Earning Date: | 11-07-2024 |
| Revenue: | $226,113,000 | Revenue Growth: | -4.33% |
| Revenue Growth (this year): | -0.51% | Revenue Growth (next year): | 7.92% |
Stock Insider Trading Activity of CryoPort Inc. (CYRX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Mandalam Ramkumar | CYRX | Director | Dec 2 '24 | Sell | $7.46 | 7,369 | $54,977.90 | 59,497 | |
| SHELTON JERRELL | CYRX | President, CEO | Nov 21 '24 | Sell | $6.49 | 72,817 | $472,887.30 | 731,897 | |
| SHELTON JERRELL | CYRX | President, CEO | Nov 18 '24 | Sell | $6.72 | 150,000 | $1,007,820.00 | 731,897 |
Latest CryoPort Inc. News
CYRX Breaking Stock News: Dive into CYRX Ticker-Specific Updates for Smart Investing
MT Newswires
3 days ago
Guggenheim Initiates Coverage on CryoPort With Buy Rating, $11 Price Target
PR Newswire
a month ago
Cryoport Expands IntegriCell™ Cryopreservation Services Solution with Opening of New Center of Excellence in Europe
Simply Wall St.
a month ago
Cryoport Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
GuruFocus.com
a month ago
CryoPort Inc (CYRX) Q3 2024 Earnings Call Highlights: Strong Service Growth Amid Market Challenges
MT Newswires
a month ago
UBS Adjusts Price Target on CryoPort to $10 From $9, Maintains Neutral Rating
Zacks
a month ago
CryoPort, Inc. (CYRX) Reports Q3 Loss, Misses Revenue Estimates
PR Newswire
a month ago
Cryoport Reports Third Quarter 2024 Financial Results
GuruFocus.com
2 months ago
CryoPort Inc (CYRX) Q3 2024: Everything You Need to Know Ahead of Earnings
Compare CYRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CYRX CryoPort Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.